|
| | Lesinurad Impurity 4 Basic information |
| Product Name: | Lesinurad Impurity 4 | | Synonyms: | 2-((5-bromo-4-(5-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid;Reginad Impurity F: 5-Cyclopropyl Reginad;Lesinurad Impurity 5/
2-[[5-Bromo-4-(5-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid;Acetic acid, 2-[[5-bromo-4-(5-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-;Oseltamivir Impuruty 5 | | CAS: | 1533519-97-9 | | MF: | C17H14BrN3O2S | | MW: | 404.28 | | EINECS: | | | Product Categories: | | | Mol File: | 1533519-97-9.mol |  |
| | Lesinurad Impurity 4 Chemical Properties |
| Boiling point | 656.7±57.0 °C(Predicted) | | density | 1.72±0.1 g/cm3(Predicted) | | pka | 2.91±0.10(Predicted) |
| | Lesinurad Impurity 4 Usage And Synthesis |
| Uses | 2-[[5-Bromo-4-(5-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid is an impurity of drug Lesinurad (L329700), which is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout. |
| | Lesinurad Impurity 4 Preparation Products And Raw materials |
|
